KARDIA-3: Zilebesiran as Add-on Therapy in Adults with Hypertension and Established Cardiovascular Disease or at High Cardiovascular Risk
30 August 2025 (16:30 - 16:40)
Organised by: 
About the speaker
Duke Clinical Research Institute, Durham (United States of America)
11 More presentations in this session
Professor B. Williams (London, GB)
Access the full session
The Event
ESC Congress 2025
30 August 2025
16:30 CET
You may be interested in
Congress Session
Congress Presentation
